Valuation: DongKook Pharmaceutical Co., Ltd.

Market Cap 965B 712M 628M 594M 539M 1.01B 68.3B 1.02B 7.13B 2.75B 34.88B 2.67B 2.61B 112B P/E 2026 *
11.4x
P/E 2027 * 9.82x
Enterprise Value 919M 678K 598K 566K 513K 962K 65.04M 972K 6.79M 2.62M 33.21M 2.55M 2.49M 107M EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.77x
Free-Float
55.72%
Yield 2026 *
0.93%
Yield 2027 * 0.93%
08-13 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-01 Faes Farma Enters Exclusive License, Supply Deal for Prostate Disease Treatment MT
05-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-22 S.Biomedics Co., Ltd. announced that it has received KRW 39.999778584 billion in funding from Hanwha Investment & Securities Co., Ltd., DongKook Pharmaceutical Co., Ltd. and other investors CI
04-13 S.Biomedics Co., Ltd. announced that it expects to receive KRW 39.999778584 billion in funding from Hanwha Investment & Securities Co., Ltd., DongKook Pharmaceutical Co., Ltd and other investors CI
03-12 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12-11 DongKook Pharmaceutical Co., Ltd. announces Annual dividend, payable on April 18, 2026 CI
12-11 Dongkook Pharmaceutical to divest 7 billion won worth of own shares RE
11-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-11 Dongkook Pharmaceutical's Net Income Rises 16% in Q2 MT
25-08-11 Dongkook Pharmaceutical Q2 operating profit 22 billion won, up 15% from year earlier RE
25-05-14 DongKook Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
1 day+1.66%
1 week+4.39%
Current month-3.82%
1 month-0.47%
3 months+13.05%
6 months-4.04%
Current year+24.78%
1 week 20,400
Extreme 20400
21,600
1 month 19,180
Extreme 19180
23,400
Current year 16,260
Extreme 16260
31,250
1 year 16,260
Extreme 16260
31,250
3 years 14,140
Extreme 14140
31,250
5 years 13,000
Extreme 13000
31,250
10 years 9,340
Extreme 9340
36,150
Manager TitleAgeSince
Chief Executive Officer 59 2022-03-24
Comptroller/Controller/Auditor 67 -
Corporate Officer/Principal 64 -
Director TitleAgeSince
Chairman 59 -
Director/Board Member 59 2022-03-24
Director/Board Member 83 2023-03-23
Date Insider Type Main position Quantity % Market Cap. Importance
4/11/24 Buy

Chief Executive Officer

6,000 0.0135%
Change 5-day change 1-year change 3-year change Capi.($)
+1.66%+4.39%+14.68%+43.62% 712M
-0.01%+1.24%+63.06%+120.55% 1,056B
-1.61%-0.60%+47.32%+71.79% 645B
-1.12%-0.72%+17.98%+76.63% 465B
+0.27%-3.50%+34.86%+41.30% 335B
+0.41%+3.28%+21.31%+30.08% 275B
-0.40%-0.50%+10.61%+12.95% 255B
+1.32%+3.27%+54.63%+57.63% 229B
-0.61%-0.91%+34.33%+101.87% 188B
-0.77%-0.89%-27.46%-60.74% 169B
Average +0.16%+0.03%+27.13%+49.57% 361.69B
Weighted average by Cap. +0.05%+0.24%+38.72%+70.98%

Financials

2026 *2027 *
Net sales 1,044B 769M 679M 642M 583M 1.09B 73.83B 1.1B 7.71B 2.97B 37.7B 2.89B 2.83B 121B 1,178B 869M 767M 726M 658M 1.23B 83.38B 1.25B 8.7B 3.35B 42.58B 3.26B 3.19B 137B
Net income 84.9B 62.6M 55.24M 52.27M 47.4M 88.87M 6.01B 89.75M 627M 242M 3.07B 235M 230M 9.87B 98.6B 72.7M 64.16M 60.7M 55.05M 103M 6.98B 104M 728M 281M 3.56B 273M 267M 11.46B
Net Debt -46.1B -33.99M -30M -28.38M -25.74M -48.25M -3.26B -48.73M -340M -131M -1.67B -128M -125M -5.36B -53.3B -39.3M -34.68M -32.81M -29.76M -55.79M -3.77B -56.34M -394M -152M -1.93B -148M -144M -6.2B
Logo DongKook Pharmaceutical Co., Ltd.
Dongkook Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company is mainly engaged in the manufacture and sale of general medicines, prescription medicines, and active pharmaceutical ingredients (APIs). In addition, the Company supplies new drugs, improved drugs, and generic medicines. Furthermore, the Company manufactures and sells cosmetics, health functional foods, and household products. The Company mainly sells its products in domestic and overseas markets.
Employees
1,285
Date Price Change Volume
26-09-29 ₩21,400.00 +1.66% 322,539
26-09-28 ₩21,050.00 -1.41% 243,318
26-09-23 ₩21,350.00 +4.15% 821,174
26-09-22 ₩20,500.00 -2.84% 376,760
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
21,400.00KRW
Average target price
30,000.00KRW
Spread / Average Target
+40.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A086450 Stock